EN
中文 EN
Company News
Home >Newsroom >Company News
ALL
2025
2024
2023
2022
2021
2020
2019
2018
2016
2015
2014
2013
2012
2007
2022.03.14
Latest Study Shows Advantages of CanSinoBIO’s Convidecia as Heterologous Booster against Omicron Variant
2022.02.20
Convidecia Approved as Heterologous Booster in China
2022.01.12
Could CanSino’s inhaled coronavirus vaccine booster be a quick, needle-free option?
2022.01.11
Latest Study Shows Encouraging Results of CanSinoBIO’s Inhaled COVID-19 Vaccine as Heterologous Booster
2022.01.07
CanSinoBIO to Present at The 40th Annual J.P. Morgan Health Care Conference
2021.12.29
CanSinoBIO Announces Approval for its MCV4 Product Menhycia™ in China
2021.12.23
Convidecia™ Phase III Results Published in The Lancet
2021.11.08
Indonesian Ambassador to China Visits CanSino SPH Biologics
2021.10.03
GLOBALink | Argentina uses Chinese CanSino COVID-19 vaccine to immunize working-class neighborhoods
2021.09.18
“Invisible Mask” for COVID Protection: Globally Innovative Inhaled Vaccine is Safer, More Effective and More Accessible
1234568